Last updated on June 2019

Evaluation of the Frequency of Occurrence of Joint Pain With Bevacizumab in Patients With Ovarian Colorectal or Bronchopulmonary Cancer


Brief description of study

Self-administered questionnaire survey to determine the presence or absence of joint pain during bevacizumab treatment for lung, ovarian, colorectal cancers.

The principal end-point is the frequency of arthralgia after 6 months of treatment with Bevacizumab.

Clinical Study Identifier: NCT03455907

Find a site near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.